Visualization of self-delivering hydrophobically modified siRNA cellular internalization

Nucleic Acids Research

Volumn 45, Issue 1, 2017, Pages 15-25

  Ly, Socheata ^a   Navaroli, Deanna M ^a   Didiot, Marie Cecile ^a   Cardia, James ^b   Pandarinathan, Lakshmipathi ^b   Alterman, Julia F ^a   Fogarty, Kevin ^a   Standley, Clive ^a   Lifshitz, Lawrence M ^a   Bellve, Karl D ^a   Prot, Matthieu ^a   Echeverria, Dimas ^a   Corvera, Silvia ^a   Khvorova, Anastasia ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b RXi Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY ENDOSOME ANTIGEN 1; EPIDERMAL GROWTH FACTOR; RBSN PROTEIN; REGULATOR PROTEIN; SMALL INTERFERING RNA; TRANSFERRIN; UNCLASSIFIED DRUG; CHOLESTEROL; CYCLOPHILIN; CYCLOPHILIN B; VESICULAR TRANSPORT PROTEIN; ZFYVE20 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CHEMICAL MODIFICATION; CONTROLLED STUDY; ENDOCYTOSIS; ENDOSOME; HYDROPHOBICITY; INTERNALIZATION; KINETICS; MICROSCOPY; NONHUMAN; PROTEIN LOCALIZATION; RNA TRANSPORT; STRUCTURED ILLUMINATION MICROSCOPY; ANIMAL; CHEMICAL PHENOMENA; CHEMISTRY; CHLOROCEBUS AETHIOPS; COS CELL LINE; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENETICS; HELA CELL LINE; HUMAN; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; CERCOPITHECUS AETHIOPS; CHOLESTEROL; COS CELLS; CYCLOPHILINS; ENDOCYTOSIS; ENDOSOMES; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION; HELA CELLS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MICROSCOPY, FLUORESCENCE; RNA, SMALL INTERFERING; TRANSFERRIN; VESICULAR TRANSPORT PROTEINS;

EID: 85016143437     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkw1005     Document Type: Article

References (83)

1. Hau, P., Jachimczak, P., Schlingensiepen, R., Schulmeyer, F., Jauch, T., Steinbrecher, A., Brawanski, A., Proescholdt, M., Schlaier, J., Buchroithner, J. et al. (2007) Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studies. Oligonucleotides, 17, 201-212.
2. Bell, D.A., Hooper, A.J., Watts, G.F. and Burnett, J.R. (2012) Mipomersen and other therapies for the treatment of severe familial hypercholesterolemia. Vasc. Health Risk Manag., 8, 651-659.
3. Wittrup, A. and Lieberman, J. (2015) Knocking down disease: a progress report on siRNA therapeutics. Nat. Rev. Genet., 16, 543-552.
4. Vaishnaw, A.K., Gollob, J., Gamba-Vitalo, C., Hutabarat, R., Sah, D., Meyers, R., de Fougerolles, T. and Maraganore, J. (2010) A status report on RNAi therapeutics. Silence, 1, 14.
5. Watts, J.K., Deleavey, G.F. and Damha, M.J. (2008) Chemically modifed siRNA: tools and applications. Drug Discov. Today, 13, 842-855.
6. Videira, M., Arranja, A., Rafael, D. and Gaspar, R. (2014) Preclinical development of siRNA therapeutics: towards the match between fundamental science and engineered systems. Nanomedicine, 10, 689-702.
7. Whitehead, K.A., Langer, R. and Anderson, D.G. (2009) Knocking down barriers: advances in siRNA delivery. Nat. Rev. Drug Discov., 8, 129-138.
8. Nair, J.K., Willoughby, J., Chan, A., Charisse, K., Alam, M.R., Wang, Q., Hoekstra, M., Kandasamy, P., Kelin, A., Milstein, S. et al. (2014) Multivalent N-Acetylgalactosamine-Conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing. Jacs, doi:10.1021/ja505986a.
9. Byrne, M., Tzekov, R., Wang, Y., Rodgers, A., Cardia, J., Ford, G., Holton, K., Pandarinathan, L., Lapierre, J., Stanney, W. et al. (2013) Novel hydrophobically modifed asymmetric RNAi compounds (sd-rxRNA) demonstrate robust effcacy in the eye. J. Ocul. Pharmacol. Ther., 29, 855-864.
10. Kanasty, R., Dorkin, J.R., Vegas, A. and Anderson, D. (2013) Delivery materials for siRNA therapeutics. Nat. Mater., 12, 967-977.
11. Stalder, L., Heusermann, W., Sokol, L., Trojer, D., Wirz, J., Hean, J., Fritzsche, A., Aeschimann, F., Pfanzagl, V., Basselet, P. et al. (2013) The rough endoplasmatic reticulum is a central nucleation site of siRNA-mediated RNA silencing. EMBO J., 32, 1115-1127.
12. Pei, Y., Hancock, P.J., Zhang, H., Bartz, R., Cherrin, C., Innocent, N., Pomerantz, C.J., Seitzer, J., Koser, M.L., Abrams, M.T. et al. (2010) Quantitative evaluation of siRNA delivery in vivo. RNA, 16, 2553-2563.
13. Gilleron, J., Querbes, W., Zeigerer, A., Borodovsky, A., Marsico, G., Schubert, U., Manygoats, K., Seifert, S., Andree, C., Stöter, M. et al. (2013) Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular traffcking and endosomal escape. Nat. Biotechnol., 31, 638-646.
14. Varkouhi, A.K., Scholte, M., Storm, G. and Haisma, H.J. (2011) Endosomal escape pathways for delivery of biologicals. J. Control. Release, 151, 220-228.
15. Koller, E., Vincent, T.M., Chappell, A., De, S., Manoharan, M. and Bennett, C.F. (2011) Mechanisms of single-stranded phosphorothioate modifed antisense oligonucleotide accumulation in hepatocytes. Nucleic Acids Res., 39, 4795-4807.
16. Love, K.T., Mahon, K.P., Levins, C.G., Whitehead, K.A., Querbes, W., Dorkin, J.R., Qin, J., Cantley, W., Qin, L.L., Racie, T. et al. (2010) Lipid-like materials for low-dose, in vivo gene silencing. Proc. Natl. Acad. Sci. U.S.A., 107, 1864-1869.
17. Semple, S.C., Akinc, A., Chen, J., Sandhu, A.P., Mui, B.L., Cho, C.K., Sah, D.W.Y., Stebbing, D., Crosley, E.J., Yaworski, E. et al. (2010) Rational design of cationic lipids for siRNA delivery. Nat. Biotechnol., 28, 172-176.
18. Rozema, D.B., Lewis, D.L., Wakefeld, D.H., Wong, S.C., Klein, J.J., Roesch, P.L., Bertin, S.L., Reppen, T.W., Chu, Q., Blokhin, A. V et al. (2007) Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes. Proc. Natl. Acad. Sci. U.S.A., 104, 12982-12987.
19. Heidel, J.D. and Schluep, T. (2012) Cyclodextrin-containing polymers: versatile platforms of drug delivery materials. J. Drug Deliv., 2012, 1-17.
20. Matsuda, S., Keiser, K., Nair, J.K., Charisse, K., Manoharan, R.M., Kretschmer, P., Peng, C.G., V Kel'in, A., Kandasamy, P., Willoughby, J.L.S. et al. (2015) siRNA conjugates carrying sequentially assembled trivalent N-acetylgalactosamine linked through nucleosides elicit robust gene silencing in vivo in hepatocytes. ACS Chem. Biol., 10, 1181-1187.
21. Rajeev, K.G., Nair, J.K., Jayaraman, M., Charisse, K., Taneja, N., O'Shea, J., Willoughby, J.L.S., Yucius, K., Nguyen, T., Shulga-Morskaya, S. et al. (2015) Hepatocyte-specifc delivery of siRNAs conjugated to novel non-nucleosidic trivalent N-acetylgalactosamine elicits robust gene silencing in vivo. ChemBioChem, 16, 903-908.
22. Sehgal, A., Barros, S., Ivanciu, L., Cooley, B., Qin, J., Racie, T., Hettinger, J., Carioto, M., Jiang, Y., Brodsky, J. et al. (2015) An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia. Nat. Med., 21, 492-497.
23. Khvorova, A., Salomon, W., Kamens, J., Samarsky, D., Woolf, T., Pavco, P. and Cardia, J. (2009) RNA interference in Skin Indications.
24. Grewal, P.K. (2010) The Ashwell-Morell receptor. Methods Enzymol., 479, 223-241.
25. Lu, J.J., Langer, R. and Chen, J. (2009) A novel mechanism is involved in cationic lipid-mediated functional siRNA delivery. Mol. Pharm., 6, 763-771.
26. Sahay, G., Querbes, W., Alabi, C., Eltoukhy, A., Sarkar, S., Zurenko, C., Karagiannis, E., Love, K., Chen, D., Zoncu, R. et al. (2013) Effciency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling. Nat. Biotechnol., 31, 653-658.
27. Wittrup, A., Ai, A., Liu, X., Hamar, P., Trifonova, R., Charisse, K., Manoharan, M., Kirchhausen, T. and Lieberman, J. (2015) Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown. Nat. Biotechnol., doi:10.1038/nbt.3298.
28. Felber, A.E., Bayó-Puxan, N., Deleavey, G.F., Castagner, B., Damha, M.J. and Leroux, J.C. (2012) The interactions of amphiphilic antisense oligonucleotides with serum proteins and their effects on in vitro silencing activity. Biomaterials, 33, 5955-5965.
29. Petrova, N.S., Chernikov, I. V., Meschaninova, M.I., Dovydenko, I.S., Venyaminova, A.G., Zenkova, M.A., Vlassov, V.V. and Chernolovskaya, E.L. (2012) Carrier-free cellular uptake and the gene-silencing activity of the lipophilic siRNAs is strongly affected by the length of the linker between siRNA and lipophilic group. Nucleic Acids Res., 40, 2330-2344.
30. Wolfrum, C., Shi, S., Jayaprakash, K.N., Jayaraman, M., Wang, G., Pandey, R.K., Rajeev, K.G., Nakayama, T., Charrise, K., Ndungo, E.M. et al. (2007) Mechanisms and optimization of in vivo delivery of lipophilic siRNAs. Nat. Biotechnol., 25, 1149-1157.
31. Kuwahara, H., Nishina, K., Yoshida, K., Nishina, T., Yamamoto, M., Saito, Y., Piao, W., Yoshida, M., Mizusawa, H. and Yokota, T. (2011) Effcient in vivo delivery of sirna into brain capillary endothelial cells along with endogenous lipoprotein. Mol. Ther., 19, 2213-2221.
32. Nishina, K., Piao, W., Yoshida-Tanaka, K., Sujino, Y., Nishina, T., Yamamoto, T., Nitta, K., Yoshioka, K., Kuwahara, H., Yasuhara, H. et al. (2015) DNA/RNA heteroduplex oligonucleotide for highly effcient gene silencing. Nat. Commun., 6, 7969.
33. Alterman, J.F., Hall, L.M., Coles, A.H., Hassler, M.R., Didiot, M.-C., Chase, K., Abraham, J., Sottosanti, E., Johnson, E., Sapp, E. et al. (2015) Hydrophobically modifed siRNAs silence huntingtin mRNA in primary neurons and mouse brain. Mol. Ther. Nucleic Acids, 4, e266.
34. Hayakawa, A., Leonard, D., Murphy, S., Hayes, S., Soto, M., Fogarty, K., Standley, C., Bellve, K., Lambright, D., Mello, C. et al. (2006) The WD40 and FYVE domain containing protein 2 defnes a class of early endosomes necessary for endocytosis. Proc. Natl. Acad. Sci. U.S.A., 103, 11928-11933.
35. Lakadamyali, M., Rust, M.J. and Zhuang, X. (2006) Ligands for clathrin-mediated endocytosis are differentially sorted into distinct populations of early endosomes. Cell, 124, 997-1009.
36. Zoncu, R., Perera, R.M., Balkin, D.M., Pirruccello, M., Toomre, D. and De Camilli, P. (2009) A phosphoinositide switch controls the maturation and signaling properties of APPL endosomes. Cell, 136, 1110-1121.
37. Leonard, D., Hayakawa, A., Lawe, D., Lambright, D., Bellve, K.D., Standley, C., Lifshitz, L.M., Fogarty, K.E. and Corvera, S. (2008) Sorting of EGF and transferrin at the plasma membrane and by cargo-specifc signaling to EEA1-enriched endosomes. J. Cell Sci., 121, 3445-3458.
38. Collinet, C., Stöter, M., Bradshaw, C.R., Samusik, N., Rink, J.C., Kenski, D., Habermann, B., Buchholz, F., Henschel, R., Mueller, M.S. et al. (2010) Systems survey of endocytosis by multiparametric image analysis. Nature, 464, 243-249.
39. Navaroli, D.M., Bellve, K.D., Standley, C., Lifshitz, L.M., Cardia, J., Lambright, D., Leonard, D., Fogarty, K.E. and Corvera, S. (2012) PNAS Plus: Rabenosyn-5 defnes the fate of the transferrin receptor following clathrin-mediated endocytosis. Proc. Natl. Acad. Sci. U. S. A., 109, E471-E480.
40. Barbieri, M.A., Roberts, R.L., Gumusboga, A., Highfeld, H., Alvarez-Dominguez, C., Wells, A. and Stahl, P.D. (2000) Epidermal growth factor and membrane traffcking. J. Cell Biol., 151, 539-550.
41. Beas, A.O., Taupin, V., Teodorof, C., Nguyen, L.T., Garcia-Marcos, M. and Farquhar, M.G. (2012) G s Promotes EEA1 endosome maturation and shuts down proliferative signaling through interaction with GIV (Girdin). Mol. Biol. Cell, 23, 4623-4634.
42. Bryant, D.M., Kerr, M.C., Hammond, L.A., Joseph, S.R., Mostov, K.E., Teasdale, R.D. and Stow, J.L. (2007) EGF induces macropinocytosis and SNX1-modulated recycling of E-cadherin. J. Cell Sci., 120, 1818-1828.
43. Yoon, H.-Y, Lee, J.-S. and Randazzo, P.A. (2008) ARAP1 regulates endocytosis of EGFR. Traffc, 9, 2236-2252.
44. Soutschek, J., Akinc, A., Bramlage, B., Charisse, K., Constien, R., Donoghue, M., Elbashir, S., Geick, A., Hadwiger, P., Harborth, J. et al (2004) Therapeutic silencing of an endogenous gene by systemic administration of modifed siRNAs. Nature, 432, 173-178.
45. Geary, R.S., Norris, D., Yu, R. and Bennett, C.F. (2015) Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides. Adv. DrugDeliv. Rev., doi:10.1016/j.addr.2015.01.008.
46. DiFiglia, M., Sena-Esteves, M., Chase, K., Sapp, E., Pfster, E., Sass, M., Yoder, J., Reeves, P, Pandey, R.K., Rajeev, K.G. et al. (2007) Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral defcits. Proc. Natl. Acad. Sci. U.S.A., 104, 17204-17209.
47. RXi Pharmaceuticals, C. (2014) A study to evaluate the effectiveness and safety of RXI 109 on the outcome of scar revision surgery in healthy adults. https://clinicaltrials.gov/ct2/show/NCT02030275.
48. Daniel, J.A., Malladi, C.S., Kettle, E., McCluskey, A. and Robinson, PJ. (2012) Analysis of synaptic vesicle endocytosis in synaptosomes by high-content screening. Nat. Protoc, 7, 1439-1455.
49. Yoshida, S., Hoppe, A.D., Araki, N. and Swanson, J.A. (2009) Sequential signaling in plasma-membrane domains during macropinosome formation in macrophages. J. Cell Sci., 122, 3250-3261.
50. Laukaitis, C.M., Webb, D.J., Donais, K. and Horwitz, A.F. (2001) Differential dynamics of alpha 5 integrin, paxillin, and alpha-actinin during formation and disassembly of adhesions in migrating cells. J. Cell Biol, 153, 1427-1440.
51. Chen, Y, Deng, L., Maeno-hikichiY., Lai, M., Chang, S., Chen, G and Zhang, J. (2003) Formation of an endophilin-Ca2+ channel complex is critical for clathrin-mediated synaptic vesicle endocytosis. Cell, 115, 37-48.
52. Butterworth, M.B., Helman, S.I. and Els, W.J. (2001) cAMP-sensitive endocytic traffcking in A6 epithelia. Am. J. Physiol. Cell Physiol., 280, C752-C762.
53. Vida, TA. and Emr, S.D. (1995) A new vital stain for visualizing vacuolar membrane dynamics and endocytosis in yeast. J. Cell Biol., 128, 779-792.
54. Chung, I., Akita, R., Vandlen, R., Toomre, D., Schlessinger, J. and Mellman, I. (2010) Spatial control of EGF receptor activation by reversible dimerization on living cells. Nature, 464, 783-787.
55. Traub, L.M. (2011) Regarding the amazing choreography of clathrin coats. PLoS Biol., 9, 3-7.
56. Bellve, K.D., Leonard, D., Standley, C, Lifshitz, L.M., Tuft, R.A., Hayakawa, A., Corvera, S. and Fogarty, K.E. (2006) Plasma membrane domains specialized for clathrin-mediated endocytosis in primary cells. J. Biol. Chem., 281, 16139-16146.
57. Nielsen, E., Christoforidis, S., Uttenweiler-Joseph, S., Miaczynska, M., Dewitte, F., Wilm, M., Hofack, B. and Zerial, M. (2000) Rabenosyn-5, a novel Rab5 effector, is complexed with hVPS45 and recruited to endosomes through a FYVE fnger domain. J. Cell Biol., 151, 601-612.
58. Lu, J. and Tsourkas, A. (2009) Imaging individual microRNAs in single mammalian cells in situ. Nucleic Acids Res., 37, 1-10.
59. Hirsch, M., Strand, D. and Helm, M. (2012) Dye selection for live cell imaging of intact siRNA. Biol. Chem., 393, 23-35.
60. Krieg, A.M., Tonkinson, J., Matson, S., Zhao, Q., Saxon, M., Zhang, L.M., Bhanja, U., Yakubov, L. and Stein, C.A. (1993) Modifcation of antisense phosphodiester oligodeoxynucleotides by a 5' cholesteryl moiety increases cellular association and improves effcacy. Proc. Natl. Acad. Sci. U.S.A., 90, 1048-1052.
61. Crooke, S.T, Graham, M.J., Zuckerman, J.E., Conklin, B.S. and Griffey, H. (1996) Pharmacokinetic Analogs in mice. J. Pharmacol Exp. Ther, 277, 923-937.
62. Sorkin, A. and Goh, L.K. (2009) Endocytosis and intracellular traffcking of ErbBs. Exp. Cell Res., 315, 683-696.
63. Madshus, I.H. and Stang, E. (2009) Internalization and intracellular sorting of the EGF receptor: a model for understanding the mechanisms of receptor traffcking. J. Cell Sci, 122, 3433-3439.
64. Cao, T.T., Mays, R.W. and von Zastrow, M. (1998) Regulated endocytosis of G-protein-coupled receptors by a biochemically and functionally distinct subpopulation of clathrin-coated pits. J. Biol. Chem., 273, 24592-24602.
65. Sönnichsen, B., De Renzis, S., Nielsen, E., Rietdorf, J. and Zerial, M. (2000) Distinct membrane domains on endosomes in the recycling pathway visualized by multicolor imaging of Rab4, Rab5, and Rab11. J. Cell Biol., 149, 901-913.
66. Wei, M.L., Bonzelius, F., Scully, R.M., Kelly, R.B. and Herman, G.A. (1998) GLUT4 and transferrin receptor are differentially sorted along the endocytic pathway in CHO cells. J. Cell Biol., 140, 565-575.
67. Trischler, M., Stoorvogel, W. and Ullrich, O. (1999) Biochemical analysis of distinct Rab5-and Rab11-positive endosomes along the transferrin pathway. J. Cell Sci., 112, 4773-4783.
68. Prekeris, R., Foletti, D.L. and Scheller, R.H. (1999) Dynamics of tubulovesicular recycling endosomes in hippocampal neurons. J. Neurosci., 19, 10324-10337.
69. Nichols, B.J. (2002) A distinct class of endosome mediates clathrin-independent endocytosis to the golgi complex. Nat. Cell Biol., 4, 374-378.
70. Daro, E., van der Sluijs, P., Galli, T. and Mellman, I. (1996) Rab4 and cellubrevin defne different early endosome populations on the pathway of transferrin receptor recycling. Proc. Natl. Acad. Sci. U. S. A., 93, 9559-9564.
71. Sheff, D., Pelletier, L., O'Connell, C.B., Warren, G. and Mellman, I. (2002) Transferrin receptor recycling in the absence of perinuclear recycling endosomes. J. Cell Biol., 156, 797-804.
72. Dautry-Varsat, A. (1986) Receptor-mediated endocytosis: the intracellular journey of transferrin and its receptor. Biochimie, 68, 375-381.
73. Hopkins, C.R., Miller, K. and Beardmore, J.M. (1985) Receptor-mediated endocytosis of transferrin and epidermal growth factor receptors: a comparison of constitutive and ligand-induced uptake. J. Cell Sci. Suppl., 3, 173-186.
74. Gibbings, D.J., Ciaudo, C., Erhardt, M. and Voinnet, O. (2009) Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat. Cell Biol., 11, 1143-1149.
75. Lee, Y.S., Pressman, S., Andress, A.P., Kim, K., White, J.L., Cassidy, J.J., Li, X., Lubell, K., Lim, D.H., Cho, I.S. et al. (2009) Silencing by small RNAs is linked to endosomal traffcking. Nat. Cell Biol., 11, 1150-1156.
76. Razi, M. and Futter, C.E. (2006) Distinct roles for Tsg101 and Hrs in multivesicular body formation and inward vesiculation. Mol. Biol. Cell, 17, 3469-3483.
77. Raiborg, C., Grønvold Bache, K., Mehlum, A., Stang, E. and Stenmark, H. (2001) Hrs recruits clathrin to early endosomes. EMBO J., 20, 5008-5021.
78. Bache, K.G., Brech, A., Mehlum, A. and Stenmark, H. (2003) Hrs regulates multivesicular body formation via ESCRT recruitment to endosomes. J. Cell Biol., 162, 435-442.
79. Oksvold, M.P., Pedersen, N.M., Forfang, L. and Smeland, E.B. (2012) Effect of cycloheximide on epidermal growth factor receptor traffcking and signaling. FEBS Lett., 586, 3575-3581.
80. Eyster, C.A., Cole, N.B., Petersen, S., Viswanathan, K., Früh, K. and Donaldson, J.G. (2011) MARCH ubiquitin ligases alter the itinerary of clathrin-independent cargo from recycling to degradation. Mol. Biol. Cell, 22, 3218-3230.
81. Patel, P.C., Giljohann, D.A., Daniel, W.L., Zheng, D., Prigodich, A.E. and Mirkin, C.A. (2010) Scavenger receptors mediate cellular uptake of polyvalent oligonucleotide-functionalized gold nanoparticles. Bioconjug. Chem., 21, 2250-2256.
82. Saleh, M.-C., van Rij, R.P., Hekele, A., Gillis, A., Foley, E., O'Farrell, P.H. and Andino, R. (2006) The endocytic pathway mediates cell entry of dsRNA to induce RNAi silencing. Nat. Cell Biol., 8, 793-802.
83. Rahajeng, J., Caplan, S. and Naslavsky, N. (2010) Common and distinct roles for the binding partners Rabenosyn-5 and Vps45 in the regulation of endocytic traffcking in mammalian cells. Exp. Cell Res., 316, 859-874.